Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Pneumonia, Viral

methylprednisolone hemisuccinate has been researched along with Pneumonia, Viral in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Awwad, C; Chin, J; Chin, K; Griffin, DO; Jensen, A; Khan, M; Parnell, R; Patel, D; Saad, J1
Forde, CT; Koumpa, FS; Manjaly, JG1

Other Studies

2 other study(ies) available for methylprednisolone hemisuccinate and Pneumonia, Viral

ArticleYear
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
    Emerging infectious diseases, 2020, Volume: 26, Issue:8

    Topics: Acute Disease; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Betacoronavirus; Biomarkers; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Cytokine Release Syndrome; Enoxaparin; Female; Fibrin Fibrinogen Degradation Products; Humans; Hypoxia; Male; Methylprednisolone Hemisuccinate; Middle Aged; Pandemics; Pneumonia, Viral; Pulmonary Embolism; Rivaroxaban; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome

2020
Sudden irreversible hearing loss post COVID-19.
    BMJ case reports, 2020, Oct-13, Volume: 13, Issue:11

    Topics: Administration, Oral; Betacoronavirus; Coronavirus Infections; COVID-19; Glucocorticoids; Hearing Loss, Sudden; Humans; Injections; Male; Methylprednisolone Hemisuccinate; Middle Aged; Pandemics; Pneumonia, Viral; Prednisolone; SARS-CoV-2

2020